Physician profile
Guy Rozen
NPI 1871903377
$55,109.70
in general payments reported to CMS, 2019-2025
10 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,823 · 2023: $13K · 2024: $23K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $25K · Food and Beverage: $18K · Consulting Fee: $5,400 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $24,898.78 |
| Food and Beverage | $17,738.36 |
| Consulting Fee | $5,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $35,663.95 | 2022-2025 | Ensite, Ensite Precision, Amplatzer Amulet |
| Biosense Webster, INC. | $11,262.09 | 2022-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic, INC. | $2,988.65 | 2023-2025 | Affera Mapping System, Pulseselect, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $2,909.99 | 2022-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Biotronik INC. | $1,626.83 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Impulse Dynamics (USA) INC. | $271.51 | 2023-2024 | Optimizer, Optimizer |
| Cardiva Medical, INC. | $200.37 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $106.31 | 2025 | |
| Philips North America LLC | $55.04 | 2025 | Lm Undivided |
| Cordis US Corp. | $24.96 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Rozen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.